David Horrobin Bibliography
1990
505
Behan, P.O.; Behan, W.M.; Horrobin, D.F.
Effect of high doses of essential fatty acids on the postviral fatigue syndrome
Acta Neurol Scand 1990; 82(3): 209-16.
(Abstract)


506
DuttaRoy, A.K.; DeMarco, A.C.; Raha, S.K.; Shay, J.; Garvey, M.; Horrobin, D.F.
Effects of linoleic and gamma-linolenic acids (Efamol evening primrose oil) on fatty acid-binding proteins of rat liver
Mol Cell Biochem 1990; 98(1-2): 177-82.
(Abstract)


507
Ells, G.; Takeda, S.; Cantrill, R.; Horrobin, D.F.
The effects of essential fatty acids on human cancer and normal cell lines
J Cancer Res Clin Oncol 1990; 116(Supp 1): 438.


508
Grattan, C.; Burton, J.L.; Manku, M.; Stewart, C.; Horrobin, D.F.
Essential-fatty-acid metabolites in plasma phospholipids in patients with ichthyosis vulgaris, acne vulgaris and psoriasis
Clin Exp Dermatol 1990; 15(3): 174-6.
(Abstract)


509
Grattan, C.E.H.; Horrobin, D.F.; Ellis, K.
Partial reversal of plasma and red cell essential fatty acid abnormalities in chronic urticaria with evening primrose oil
J Dermatol Treat 1990; 1: 227-228.


510
Horrobin, D.F.
Lowering cholesterol concentrations and mortality (VIII)
Br Med J 1990; 301(6751): 554-555.


511
Horrobin, D.F.
Essential fatty acids, psychiatric disorders, and neuropathies
In: Horrobin D.F. (Ed.) Omega-6 essential fatty acids. Pathophysiology and roles in clinical medicine. Alan R. Liss, New York. 1990: 305-20.
(Abstract)


512
Horrobin, D.F.
Essential fatty acids, lipid peroxidation, and cancer
In: Horrobin D.F. (Ed.) Omega-6 essential fatty acids. Pathophysiology and roles in clinical medicine. Alan R. Liss, New York. 1990: 351-78.
(Abstract)


513
Horrobin, D.F.
Essential fatty acids, lipid peroxidation, and cancer
In: Horrobin, D.F. (Ed). Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical Medicine. Alan R. Liss, Inc., New York. 1990: 351-377.


514
Horrobin, D.F.
Essential fatty acids, psychiatric disorders, and neuropathies
In: Horrobin, D.F. (Ed.) Omega-6 Essential Fatty Acids: Pathophysiology and Roles in Clinical Medicine. Alan R. Liss, Inc., New York. 1990: 305-319.
(Full text)  

515
Horrobin, D.F.
Lithium and dermatological disorders
In: Lithium and cell physiology. Bach, RO and Gallicchio, VS (eds.), 1990: 158-167.


516
Horrobin, D.F.
Essential fatty acids, prostaglandins and schizophrenia
In: Stefanis, C.N. et al. (Eds.). Psychiatry: A World Perspective. Elsevier Science Publishers. 1990; 2: 140-144.


517
Horrobin, D.F.
Essential omega-6 and omega-3 fatty acids in medicine: a practical guide
J Adv Med 1990; 3(3): 151-161.


518
Horrobin, D.F.
The philosophical basis of peer review and the suppression of innovation
J Am Med Assoc 1990; 263(10): 1438-41.
(Abstract)


519
Horrobin, D.F.
Essential fatty acids, immunity and viral infections
J Nutr Med 1990; I: 145-151.


520
Horrobin, D.F.
Scientists leaving science [letter]
Lancet 1990; 335(8692): 796-7.


521
Horrobin, D.F.
Lithium, fatty acids and seborrhoeic dermatitis: A new mechanism of lithium action and a new treatment for seborrhoeic dermatitis
Lithium 1990; 1: 149-155.


522
Horrobin, D.F.
A self-help guide to chronic fatigue syndrome
Living Naturally 1990; 2(2): 14.


523
Horrobin, D.F.
Post-viral fatigue syndrome, viral infections in atopic eczema, and essential fatty acids
Med Hypotheses 1990; 32(3): 211-217.
(Abstract)


524
Horrobin, D.F.
Evening primrose oil and premenstrual syndrome [letter]
Med J Aust 1990; 153(10): 630-1.


525
Horrobin, D.F.
Cardiovascular and inflammatory disease: interactions between omega-3 and omega-6 essential fatty acids (EFAs)
Omega-3 News 1990; 5(3): 1-5.


526
Horrobin, D.F.
Gamma linolenic acid: an intermediate in essential fatty acid metabolism with potential as an ethical pharmaceutical and as a food [review]
Rev Contemp Pharmacother 1990; 1(1): 1-41.
(Abstract)


527
Horrobin, D.F.
Discouraging hypotheses slows progress
The Scientist 1990; 4(23): 13,15.


528
Horrobin, D.F. (ed.)
Omega-6 essential fatty acids. Pathophysiology and roles in clinical medicine
Wiley-Liss, New York. 595pp 1990.


529
Horrobin, D.F.; Dobbin, S.; Reynolds, B.
Plasma fatty acids in dogs and their response to essential fatty acid supplementation
In: von Tscharner, C.; Halliwell, R.F.W. (Eds.) Veterinary Dermatology. Bailliere Tindall. London. 1990: 473-474.


530
Horrobin, D.F.; Dobbin, S.; Reynolds, B.
Omega-3 and omega-6 essential fatty acids (EFAS) and the skin
In: von Tscharner, C.; Halliwell, R.F.W. (Eds.) Veterinary Dermatology. Bailliere Tindall. London. 1990: 475.


531
Horrobin, D.F. and Manku, M.
Clinical biochemistry of essential fatty acids
In: Horrobin D.F. (Ed.) Omega-6 essential fatty acids. Pathophysiology and roles in clinical medicine. Alan R. Liss, New York. 1990: 21-53.
(Abstract)


532
Horrobin, D.F. and Manku, M.S.
Fatty acids in red cell membranes in patients with post-viral fatigue syndrome (myalgic encephalomyelitis)
Inform 1990; 1(4): 332.


533
Horrobin, D.F. and Stewart, C.
Evening primrose oil in atopic eczema [letter]
Lancet 1990; 335(8693): 864-5.


534
Horrobin, D.F. and Stewart, C.
Evening primrose oil and atopic eczema [letter]
Lancet 1990; 336(8706): 50.


535
Huang, Y.S.; Horrobin, D.F.; Watanabe, Y.; Bartlett, M.E.; Simmons, V.A.
Effects of dietary linoleic acid on growth and liver phospholipid fatty acid composition in intact and gonadectomized rats
Biochem Arch 1990; 6: 47-54.


536
Huang, Y.S.; Mills, D.E.; Ward, R.P.; Simmons, V.A.; Horrobin, D.F.
Stress modulates cholesterol-induced changes in plasma and liver fatty acid composition in rats fed n-6 fatty acid-rich oils
Proc Soc Exp Biol Med 1990; 195(1): 136-41.
(Abstract)


537
Huang, Y.S.; Watanabe, Y.; Horrobin, D.F.; Simmons, V.
The effects of dietary protein and cholesterol on tissue cholesterol contents and N-6 fatty acid compositions in rats and mice fed a gamma-linolenate-rich diet
In: Sugano, M.; Beynen, A.C. (Eds.) Dietary proteins, cholesterol metabolism and atherosclerosis (Monographs in Atherosclerosis). Karger, Basel. 1990; 16: 11-25.


538
Oxholm, A.; Oxholm, P.; da Cunha Bang, F.; Horrobin, D.F.
Abnormal essential fatty acid metabolism in Darier's disease
Arch Dermatol 1990; 126(10): 1308-11.
(Abstract)


539
Oxholm, P.; Rasmussen, N.; Manthorpe, R.; Horrobin, D.F.
Treatment with n-6 essential fatty acids as evening primrose oil in patients with Wegener's granulomatosis
In: Horrobin D.F. (Ed.) Omega-6 essential fatty acids. Pathophysiology and roles in clinical medicine. Alan R. Liss, New York. 1990: 255-260.


540
Oxholm, P.; Rasmussen, N.; Manthorpe, R.; Horrobin, D.F.
Treatment with n-6 essential fatty acids as evening primrose oil in patients with Wegener's granulomatosis
In: Horrobin D.F. (Ed.) Omega-6 essential fatty acids. Pathophysiology and roles in clinical medicine. Alan R. Liss, New York. 1990: 255-60.
(Abstract)


541
Takahashi, R.; Manku, M.S.; Jenkins, K.; Horrobin, D.F.
Age-associated reduction of prostacyclin and thromboxane synthesis is inversely related to plasma cholesterol levels: modulation by dietary cholesterol supplementation
Prostaglandins Leukotr EFAs 1990; 39(1): 65-7.
(Abstract)


542
Takeda, S.; Horrobin, D.F.; Manku, M.; Ells, G.; Sanford, T.; Simmons, V.
Lipid peroxide and Schiff reactive material produced by GLA-treated cancer cells
Free Radic Biol Med 1990; 9(Supp 1): 174.


543
Wright, S.; Horrobin, D.F.; Manku, M.
Deficient conversion of linoleic acid [letter]
J Am Acad Dermatol 1990; 23(3 Pt 1): 533-6.




All copyrights acknowledged

© Peter Lapinskas 1999-2012 Email Peter Lapinskas Last updated: 3 July 2012

Home      Services      Background      Publications      Resources      Contact